Grifols retains penchant for dollars in jumbo refi

Spanish pharmaceutical company Grifols is raising the vast majority of its new $4.8bn-equivalent refinancing loan package in dollars, matching its revenues and retaining a debt structure that will rely more on investors in the US than in Europe.